Cargando…

Profiling of Humoral Response to Influenza A(H1N1)pdm09 Infection and Vaccination Measured by a Protein Microarray in Persons with and without History of Seasonal Vaccination

BACKGROUND: The influence of prior seasonal influenza vaccination on the antibody response produced by natural infection or vaccination is not well understood. METHODS: We compared the profiles of antibody responses of 32 naturally infected subjects and 98 subjects vaccinated with a 2009 influenza A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huijskens, Elisabeth G. W., Reimerink, Johan, Mulder, Paul G. H., van Beek, Janko, Meijer, Adam, de Bruin, Erwin, Friesema, Ingrid, de Jong, Menno D., Rimmelzwaan, Guus F., Peeters, Marcel F., Rossen, John W. A., Koopmans, Marion
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3554683/ https://www.ncbi.nlm.nih.gov/pubmed/23365683 http://dx.doi.org/10.1371/journal.pone.0054890

Ejemplares similares

Randomized Controlled Ferret Study to Assess the Direct Impact of 2008–09 Trivalent Inactivated Influenza Vaccine on A(H1N1)pdm09 Disease Risk
por: Skowronski, Danuta M., et al.
Publicado: (2014)

Host immunity dictates influenza A(H1N1)pdm09 infection outcome in hematology–oncology patients
por: Gooskens, J, et al.
Publicado: (2015)

A(H1N1)pdm09 influenza infection: vaccine inefficiency
por: Friedman, Nehemya, et al.
Publicado: (2017)

Getting More Out of Less – A Quantitative Serological Screening Tool for Simultaneous Detection of Multiple Influenza A Hemagglutinin-Types in Chickens
por: Freidl, Gudrun S., et al.
Publicado: (2014)

Effectiveness of A(H1N1)pdm09 Influenza Vaccine in Adults Recommended for Annual Influenza Vaccination
por: Gefenaite, Giedre, et al.
Publicado: (2013)

Augmented CD4(+) T-cell and humoral responses after repeated annual influenza vaccination with the same vaccine component A/H1N1pdm09 over 5 years
por: Trieu, Mai-Chi, et al.
Publicado: (2018)

Safety of Influenza A H1N1pdm09 Vaccines: An Overview of Systematic Reviews
por: Juvet, Lene Kristine, et al.
Publicado: (2021)

Viral vector-based influenza vaccines
por: de Vries, Rory D., et al.
Publicado: (2016)

Repeated Influenza Vaccination Boosts and Maintains H1N1pdm09 Neuraminidase Antibody Titers
por: Hansen, Lena, et al.
Publicado: (2021)

Responses to A(H1N1)pdm09 Influenza Vaccines in Participants Previously Vaccinated With Seasonal Influenza Vaccine: A Randomized, Observer-Blind, Controlled Study
por: Roy-Ghanta, Sumita, et al.
Publicado: (2014)

Publisher Correction: Augmented CD4(+) T-cell and humoral responses after repeated annual influenza vaccination with the same vaccine component A/H1N1pdm09 over 5 years
por: Trieu, Mai-Chi, et al.
Publicado: (2018)

No Association between 2008–09 Influenza Vaccine and Influenza A(H1N1)pdm09 Virus Infection, Manitoba, Canada, 2009
por: Mahmud, Salaheddin M., et al.
Publicado: (2012)

Differential Influence of Age on the Relationship between Genetic Mismatch and A(H1N1)pdm09 Vaccine Effectiveness
por: Cao, Lirong, et al.
Publicado: (2021)

Adaptive Immunity to Dengue Virus: Slippery Slope or Solid Ground for Rational Vaccine Design?
por: Wilken, Lucas, et al.
Publicado: (2020)

Towards universal influenza vaccines?
por: Osterhaus, Ab, et al.
Publicado: (2011)

Immune Responses in Pigs Vaccinated with Adjuvanted and Non-Adjuvanted A(H1N1)pdm/09 Influenza Vaccines Used in Human Immunization Programmes
por: Lefevre, Eric A., et al.
Publicado: (2012)

Advances in influenza vaccination
por: Reperant, Leslie A., et al.
Publicado: (2014)

Long-Term Persistence of Cell-Mediated and Humoral Responses to A(H1N1)pdm09 Influenza Virus Vaccines and the Role of the AS03 Adjuvant System in Adults during Two Randomized Controlled Trials
por: van der Most, Robbert G., et al.
Publicado: (2017)

No Evidence for Disease History as a Risk Factor for Narcolepsy after A(H1N1)pdm09 Vaccination
por: Lamb, Favelle, et al.
Publicado: (2016)

Effectiveness of MF59™ Adjuvanted Influenza A(H1N1)pdm09 Vaccine in Risk Groups in the Netherlands
por: Wijnans, Leonoor, et al.
Publicado: (2013)

Bell’s palsy and influenza(H1N1)pdm09 containing vaccines: A self-controlled case series
por: Wijnans, Leonoor, et al.
Publicado: (2017)

Non‐neutralizing antibody responses following A(H1N1)pdm09 influenza vaccination with or without AS03 adjuvant system
por: Friel, Damien, et al.
Publicado: (2020)

Influence of renal replacement therapy on immune response after one and two doses of the A(H1N1) pdm09 vaccine
por: Quintana, Luis F., et al.
Publicado: (2012)

Single dose vaccination of the ASO3-adjuvanted A(H1N1)pdm09 monovalent vaccine in health care workers elicits homologous and cross-reactive cellular and humoral responses to H1N1 strains
por: Lartey, Sarah, et al.
Publicado: (2015)

Publisher Correction: Specific memory B cell response in humans upon infection with highly pathogenic H7N7 avian influenza virus
por: Westerhuis, Brenda, et al.
Publicado: (2020)

Specific memory B cell response in humans upon infection with highly pathogenic H7N7 avian influenza virus
por: Westerhuis, Brenda, et al.
Publicado: (2020)

Beliefs and Knowledge about Vaccination against AH1N1pdm09 Infection and Uptake Factors among Chinese Parents
por: Wu, Cynthia Sau Ting, et al.
Publicado: (2014)

Pandemic Influenza A(H1N1)pdm09 Seroprevalence in Sweden before and after the Pandemic and the Vaccination Campaign in 2009
por: Mörner, Andreas, et al.
Publicado: (2012)

Antibody response to influenza A(H1N1)pdm09 in vaccinated, serologically infected and unaffected pregnant women and their newborns
por: Helmig, Rikke B., et al.
Publicado: (2015)

Non-neutralizing antibodies induced by seasonal influenza vaccine prevent, not exacerbate A(H1N1)pdm09 disease
por: Kim, Jin Hyang, et al.
Publicado: (2016)

Influenza A(H1N1)pdm09 virus and asthma
por: Obuchi, Masatsugu, et al.
Publicado: (2013)

Effects of pre-existing orthopoxvirus-specific immunity on the performance of Modified Vaccinia virus Ankara-based influenza vaccines
por: Altenburg, Arwen F., et al.
Publicado: (2018)

Developing Universal Influenza Vaccines: Hitting the Nail, Not Just on the Head
por: Wiersma, Lidewij C. M., et al.
Publicado: (2015)

Development of PREDAC-H1pdm to model the antigenic evolution of influenza A/(H1N1) pdm09 viruses
por: Liu, Mi, et al.
Publicado: (2023)

Usefulness of health registries when estimating vaccine effectiveness during the influenza A(H1N1)pdm09 pandemic in Norway
por: Guzmán Herrador, Bernardo Rafael, et al.
Publicado: (2012)

Efficiency of Points of Dispensing for Influenza A(H1N1)pdm09 Vaccination, Los Angeles County, California, USA, 2009
por: Saha, Shubhayu, et al.
Publicado: (2014)

Influenza A(H1N1)pdm09 vaccine effectiveness and other characteristics associated with hospitalization in chronic liver disease patients
por: Ohfuji, Satoko, et al.
Publicado: (2014)

Immunogenicity of influenza A(H1N1)pdm09 vaccine and the associated factors on lowered immune response in patients with hepatitis C
por: Ohfuji, Satoko, et al.
Publicado: (2012)

Interim estimates of 2018/19 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, January 2019
por: Skowronski, Danuta M, et al.
Publicado: (2019)

Assessing the Intense Influenza A(H1N1)pdm09 Epidemic and Vaccine Effectiveness in the Post-COVID Season in the Russian Federation
por: Sominina, Anna, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pc4i1m6fsnnmp3sm2hv5kfik52